TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Pain And Inflammation Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Pain And Inflammation Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Pain And Inflammation Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Pain And Inflammation Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Pain And Inflammation Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Pain And Inflammation Drugs industry

Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025MAIWALD
Suppression Of Bone Cancer-Induced AllodyniaIPSEN BIOPHARMJun 18, 2025MERZ PHARMA
Substituted Tetrahydrofurans As Modulators Of Sodium ChannelsVERTEX PHARMACEUTICALS INCORPORATEDJun 17, 2025BARDEHLE PAGENBERG
Capsule FormulationsCHEMOCENTRYXJun 12, 2025LEK PHARMACEUTICALS DD
Novel 2,4-Dinitrophenol Formulations And Methods Using SameYALE UNIVERSITYJan 17, 2025MITO PHARMACEUTICALS
Injectable Long-Acting Naltrexone Microparticle CompositionsCHONG KUN DANG PHARMACEUTICALNov 6, 2024ALKERMES PHARMA IRELAND
Pharmaceutical Compositions Comprising A Jak InhibitorGILEAD SCIENCESSep 20, 2024POLPHARMA
Pharmaceutical Compositions Comprising A Jak InhibitorGALAPAGOSSep 17, 2024TEVA PHARMACEUTICALS
An Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Disorder In Feline AnimalsBOEHRINGER INGELHEIM VETMEDICAJul 24, 2024ELANCO

To stay ahead in the competitive Pain And Inflammation Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Pain And Inflammation Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
Jul 27, 2022Use Of Dpp Iv InhibitorsBOEHRINGER INGELHEIM5
May 29, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENE5
Dec 25, 2024Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALS4
Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsGRNENTHAL4
May 6, 2020Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPE3
Dec 20, 2023Pharmaceutical Compositions Comprising A Jak InhibitorGILEAD SCIENCES3
Mar 27, 2019Corticosteroid CompositionsMERITAGE PHARMA2
Sep 14, 2022A Xanthine Derivative As Dpp-4 Inhibitor For Use In The Treatment Of Sirs And/Or SepsisBOEHRINGER INGELHEIM2
Aug 2, 2017Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The SameRINAT NEUROSCIENCE2